Jump to content

L-xylulose reductase

From Wikipedia, the free encyclopedia
(Redirected from EC 1.1.1.10)
DCXR
Identifiers
AliasesDCXR, DCR, HCR2, HCRII, KIDCR, P34H, PNTSU, SDR20C1, XR, dicarbonyl/L-xylulose reductase, dicarbonyl and L-xylulose reductase
External IDsOMIM: 608347; MGI: 1915130; GeneCards: DCXR
Available structures
PDBOrtholog search: PDBe RCSB
Enzyme activity
EC #BRENDAExPASyKEGGMetaCyc
1.1.1.10↗↗↗↗
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_016286
NM_001195218

NM_026428
NM_001347608

RefSeq (protein)

NP_001182147
NP_057370

NP_001334537
NP_080704

Location (UCSC)Chr 17: 82.04 – 82.04 MbChr 11: 120.62 – 120.62 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse
L-xylulose reductase
L-Xylulose reductase tetramer, Human
Identifiers
EC no.1.1.1.10
Databases
BRENDAenzyme data
ExPASyNiceZyme view
KEGGenzyme entry
MetaCycmetabolic pathway
Rheareactions
PDB structuresRCSB PDB PDBe PDBsum
Search
PMCarticles
PubMedarticles
NCBIproteins

Dicarbonyl/L-xylulose reductase, also known as carbonyl reductase II, is an enzyme that in human is encoded by the DCXR gene located on chromosome 17.

Structure

[edit]

The DCXR gene encodes a membrane protein that is approximately 34 kDa in size and composed of 224 amino acids. The protein is highly expressed in the kidney and localizes to the cytoplasmic membrane.[5]

Function

[edit]

DCSR catalyzes the reduction of several L-xylylose as well as a number of pentoses, tetroses, trioses, alpha-dicarbonyl compounds. The enzyme is involved in carbohydrate metabolism, glucose metabolism, the uronate cycle and may play a role in the water absorption and cellular osmoregulation in the proximal renal tubules by producing xylitol.[6]

In enzymology, L-xylulose reductase (EC 1.1.1.10) is an enzyme that catalyzes the chemical reaction

 
 
 
H+
Reversible left-right reaction arrow with minor forward product(s) to top right and minor reverse substrate(s) from bottom right
 
H+
 
 

Its two substrates are xylitol and the oxidised cofactor nicotinamide adenine dinucleotide phosphate (NADP+). The products are L-xylulose, reduced NADPH, and a proton.[7]

This enzyme belongs to the superfamily of short-chain oxidoreductases, specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is xylitol:NADP+ 2-oxidoreductase (L-xylulose-forming).

Clinical significance

[edit]

A deficiency is responsible for pentosuria. The insufficiency of L-xylulose reductase activity causes an inborn error of metabolism disease characterized by excessive urinary excretion of L-xylulose.

Over-expression and ectopic expression of the protein may be associated with prostate adenocarcinoma.[8]

See also

[edit]

References

[edit]
  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000169738 – Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000039450 – Ensembl, May 2017
  3. ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ↑ Nakagawa J, Ishikura S, Asami J, Isaji T, Usami N, Hara A, Sakurai T, Tsuritani K, Oda K, Takahashi M, Yoshimoto M, Otsuka N, Kitamura K (2002). "Molecular characterization of mammalian dicarbonyl/L-xylulose reductase and its localization in kidney". J. Biol. Chem. 277 (20): 17883–91. doi:10.1074/jbc.M110703200. PMID 11882650.
  6. ↑ Zhao HT, Endo S, Ishikura S, Chung R, Hogg PJ, Hara A, El-Kabbani O (2009). "Structure/function analysis of a critical disulfide bond in the active site of L-xylulose reductase". Cell. Mol. Life Sci. 66 (9): 1570–9. doi:10.1007/s00018-009-9065-y. PMC 11131457. PMID 19337691. S2CID 8332906.
  7. ↑ Enzyme 1.1.1.10 at KEGG Pathway Database.
  8. ↑ Cho-Vega JH, Tsavachidis S, Do KA, Nakagawa J, Medeiros LJ, McDonnell TJ (2007). "Dicarbonyl/L-xylulose reductase: a potential biomarker identified by laser-capture microdissection-micro serial analysis of gene expression of human prostate adenocarcinoma". Cancer Epidemiol. Biomarkers Prev. 16 (12): 2615–22. doi:10.1158/1055-9965.EPI-07-0684. PMID 18086765.
[edit]